BPC-157: The peptide with big claims and scant evidence
A co-published investigation by STAT and Undark examines the scientific literature behind BPC-157's popularity, finding that nearly all existing data originates from a single Croatian research group's rodent studies. A University of Utah chief medical resident's formal literature review found the animal evidence for angiogenesis, anti-inflammatory, and tendon-healing effects credible in rodents, but identified no adequately powered human trials supporting the therapeutic claims driving the compound's popularity.
This is a summary. The reporting is STAT News's, and the link below goes to the original article.